Orchestra Biomed logo

Orchestra Biomed Share Price (NASDAQ: OBIO)

$2.74

0.03

(1.11%)

Last updated on

Check the interactive Orchestra Biomed Stock chart to analyse performance

Orchestra Biomed stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.68
    Today's High:$2.75

    Day's Volatility :2.55%

  • 52 Weeks Low:$2.37
    52 Weeks High:$6.89

    52 Weeks Volatility :65.6%

Orchestra Biomed Stock Returns

PeriodOrchestra Biomed Holdings IncIndex (Russel 2000)
3 Months
-13.61%
0.0%
6 Months
-33.41%
0.0%
1 Year
-56.46%
0.0%
3 Years
-76.26%
-4.1%

Orchestra Biomed Holdings Inc Key Stats

Check Orchestra Biomed key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.71
Open
$2.7
Today's High
$2.75
Today's Low
$2.68
Market Capitalization
$146.2M
Today's Volume
$124.0K
52 Week High
$6.89
52 Week Low
$2.37
Revenue TTM
$2.9M
EBITDA
$-70.9M
Earnings Per Share (EPS)
$-1.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-313.82%

Stock Returns calculator for Orchestra Biomed Stock including INR - Dollar returns

The Orchestra Biomed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Orchestra Biomed investment value today

Current value as on today

₹48,984

Returns

₹51,016

(-51.02%)

Returns from Orchestra Biomed Stock

₹56,300 (-56.3%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Orchestra Biomed Stock

-25%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Orchestra Biomed Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Orchestra Biomed Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Orchestra Biomed(by analysts ranked 0 to 5 stars)

Orchestra Biomed Share Price Target

What analysts predicted

Upside of 404.86%

Target:

$13.83

Current:

$2.74

Orchestra Biomed share price target is $13.83, a slight Upside of 404.86% compared to current price of $2.74 as per analysts' prediction.

Orchestra Biomed Stock Insights

  • Price Movement

    In the last 7 days, OBIO stock has moved up by 7.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 868.0K → 836.0K (in $), with an average decrease of 3.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -15.42M → -19.36M (in $), with an average decrease of 8.0% per quarter
  • OBIO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 129.2%
  • Price to Sales

    ForOBIO every $1 of sales, investors are willing to pay $35.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Orchestra Biomed Holdings Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$2.6M
↓ 4.42%
Net Income
$-61.0M
↑ 24.23%
Net Profit Margin
-2.3K%
↓ 533.56%

Orchestra Biomed Technicals Summary

Sell

Neutral

Buy

Orchestra Biomed is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Orchestra Biomed Holdings Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Orchestra Biomed Holdings Inc logo
11.89%
-33.41%
-56.46%
-76.26%
-76.26%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Orchestra Biomed Holdings Inc

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Organization
Orchestra Biomed
Employees
70
CEO
Mr. David P. Hochman
Industry
Miscellaneous

Key Management of Orchestra Biomed Holdings Inc

NameTitle
Mr. David P. Hochman
Founder, Chairman of the Board of Directors & CEO
Mr. Darren R. Sherman
Founder, President, COO & Director
Mr. Andrew Lawrence Taylor M.B.A.
Chief Financial Officer
Mr. William Reed Little
Executive Vice President of Corporate Development & Strategy
Dr. Yuval Hay Mika D.Sc, Ph.D.
GM & CTO of Bioelectronic Therapies
Dr. Hans-Peter Stoll M.D., Ph.D.
Chief Clinical Officer
Dr. Avraham Matityahu Fischer M.D.
Senior Vice President of Medical Affairs & Innovation
Mr. Bob Laughner
Senior Vice President of Regulatory & Quality
Mr. Juan Lorenzo
Senior Vice President of Product Development
Mr. Mark Pomeranz
GM & Executive VP of Interventional Therapies

Important FAQs about investing in OBIO Stock from India :

What is Orchestra Biomed share price today?

Orchestra Biomed share price today is $2.74 as on at the close of the market. Orchestra Biomed share today touched a day high of $2.75 and a low of $2.68.

What is the 52 week high and 52 week low for Orchestra Biomed share?

Orchestra Biomed share touched a 52 week high of $6.89 and a 52 week low of $2.37. Orchestra Biomed stock price today i.e. is closed at $2.74, lower by 60.23% versus the 52 week high.

How to invest in Orchestra Biomed Stock (OBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Orchestra Biomed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Orchestra Biomed Shares that will get you 0.5474 shares as per Orchestra Biomed share price of $2.74 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Orchestra Biomed Stock (OBIO) from India?

Indian investors can start investing in Orchestra Biomed (OBIO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Orchestra Biomed stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Orchestra Biomed share’s latest price of $2.74 as on August 30, 2025 at 1:29 am IST, you will get 3.6496 shares of Orchestra Biomed. Learn more about fractional shares .

What are the returns that Orchestra Biomed has given to Indian investors in the last 5 years?

Orchestra Biomed stock has given -76.26% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?